FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% TRAVOPROST — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals' Travoprost ophthalmic solution 0.004% as a generic product under an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% TRAVOPROST (travoprost ophthalmic solution 0.004%)

Snippet

ORIG AP for TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% TRAVOPROST (TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004%)